Meeting
2014 ASCO Annual Meeting
Phase II study of single-agent cetuximab in KRAS G13D mutant metastatic colorectal cancer (mCRC).
Authors
Marta Schirripa
U.O. Oncologia Medica 2, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa, Italy
Marta Schirripa , Sara Lonardi , Chiara Cremolini , Fotios Loupakis , Lisa Salvatore , Francesca Bergamo , Carlotta Antoniotti , Anna Roma , Roberta Bertorelle , Gianluca Masi , Federica Marmorino , Daniele Rossini , Giulia Pasquini , Federica Zoratto , Vittorina Zagonel , Alfredo Falcone
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 3524)
DOI
10.1200/jco.2014.32.15_suppl.3524
Abstract #
3524
Poster Bd #
12
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Analysis of RAS/BRAF mutations in a randomized phase II WJOG6510G study of panitumumab plus irinotecan versus cetuximab plus irinotecan in chemorefractory metastatic colorectal cancer.
First Author: Tomohiro Nishina
Poster
2016 ASCO Annual Meeting
Sorafenib (Soraf) and irinotecan (Iri) combination for pretreated RAS-mutated metastatic colorectal cancer (mCRC) patients: A multicentre randomized phase II trial (NEXIRI 2-PRODIGE 27).
First Author: Emmanuelle Samalin
Poster
2016 Gastrointestinal Cancers Symposium
Sorafenib and irinotecan combination for pre-treated RAS-mutated metastatic colorectal cancer patients: A multicentre randomized phase II trial (NEXIRI 2).
First Author: Emmanuelle Samalin
Poster
2016 Gastrointestinal Cancers Symposium
KEYNOTE-164: Phase II study of pembrolizumab (MK-3475) for patients with previously treated, microsatellite instability-high advanced colorectal carcinoma.
First Author: Dung T. Le